Trial intelligence / Profile preview

Repeated intravenous boluses of flecainide versus standard quick infusion for acute atrial fibrillation termination

2007-000204-33Phase 3Active

Sponsor
ASST Sette Laghi
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of flecainide in Atrial fibrillation (AFib) (2 arms), sponsored by ASST Sette Laghi. Started Feb 2007; status: active.

02

Drugs

flecainide
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on 2007-000204-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000204-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call